In Vitro Activity of Ceftibuten-Avibactam against β-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program

Ceftibuten is an established, oral, third-generation cephalosporin in early clinical development in combination with an oral prodrug of avibactam for the treatment of complicated urinary tract infections, including acute pyelonephritis. We evaluated the in vitro activity of ceftibuten-avibactam agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlowsky, James A., Hackel, Meredith A., Stone, Gregory G., Sahm, Daniel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Susceptibility
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872606/
https://www.ncbi.nlm.nih.gov/pubmed/36602322
http://dx.doi.org/10.1128/aac.01346-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872606/
https://www.ncbi.nlm.nih.gov/pubmed/36602322
http://dx.doi.org/10.1128/aac.01346-22

Ejemplares similares